Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Current Taxes (2023 - 2025)

China Pharma Holdings' Current Taxes history spans 7 years, with the latest figure at $351904.0 for Q4 2025.

  • For Q4 2025, Current Taxes fell 20.21% year-over-year to $351904.0; the TTM value through Dec 2025 reached $351904.0, down 20.21%, while the annual FY2025 figure was $351904.0, 20.21% down from the prior year.
  • Current Taxes reached $351904.0 in Q4 2025 per CPHI's latest filing, down from $691677.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.0 million in Q4 2023 to a low of $351904.0 in Q4 2025.
  • Average Current Taxes over 3 years is $601079.9, with a median of $555142.0 recorded in 2025.
  • Peak YoY movement for Current Taxes: tumbled 57.06% in 2024, then soared 73.26% in 2025.
  • A 3-year view of Current Taxes shows it stood at $1.0 million in 2023, then crashed by 57.06% to $441062.0 in 2024, then decreased by 20.21% to $351904.0 in 2025.
  • Per Business Quant, the three most recent readings for CPHI's Current Taxes are $351904.0 (Q4 2025), $691677.0 (Q3 2025), and $741376.0 (Q2 2025).